← Back to Clinical Trials
Recruiting NCT06968052

NCT06968052 Effects of Feldenkrais Approach in Cases With Forward Head Posture

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06968052
Status Recruiting
Phase
Sponsor Istanbul University - Cerrahpasa
Condition Forward Head Posture
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-05-25
Primary Completion 2026-05-05

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Strength and Feldenkrais ExerciseStrength Exercise

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-05-25 with a primary completion date of 2026-05-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

It is thought that adding approaches that increase posture awareness to corrective exercise programs will contribute to the treatment. The aim of the study is to evaluate the effect of adding the Feldenkrais method to the corrective exercise program applied to individuals with forward head posture on cervical joint position sense, muscle strength, joint range of motion and posture parameters.

Eligibility Criteria

Inclusion Criteria: * Being between 18-65 years of age * CVA (cervicovertebral angle) ≤50° (16,17) * Spending at least 4 hours of daily desk time 5 days a week Exclusion Criteria: * Having temporomandibular dysfunction * Having any spinal deformity * Having cervical trauma or pain treatment within the last 6 months * Having previously participated in a corrective exercise program * History of neurological disorder * History of spinal or thoracic surgery * Having hearing impairment * Use of analgesics/muscle relaxants

Contact & Investigator

Principal Investigator

Ayşe Zengin Alpözgen, Assoc. Prof.

PRINCIPAL INVESTIGATOR

Istanbul University - Cerrahpasa

Frequently Asked Questions

Who can join the NCT06968052 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Forward Head Posture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06968052 currently recruiting?

Yes, NCT06968052 is actively recruiting participants. Visit ClinicalTrials.gov or contact Istanbul University - Cerrahpasa to inquire about joining.

Where is the NCT06968052 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye), Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT06968052 clinical trial?

NCT06968052 is sponsored by Istanbul University - Cerrahpasa. The principal investigator is Ayşe Zengin Alpözgen, Assoc. Prof. at Istanbul University - Cerrahpasa. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology